Ajanta Pharmaceuticals
AJANTPHARM
₹ 2,897.61
₹ 0.52
0.02%
Healthcare
₹ 0.00
(%)1D
Updated: 21 Nov 2024, 03:31:04 pm IST
Stock Score
Open Price
₹ 2,886.17
Prev. Close
₹ 2,897.09
₹ 2,853.49
Day Low
₹ 2,918.19
Day High
₹ 1,896.16
52 Week Low
₹ 3,459.84
52 Week High
Quick Bite
Price To Earnings Ratio 44.70 | Sector PE 64.19 |
PB Ratio 10.24 | Sector PB 8.77 |
EPS 64.83 | Dividend Yield 2.28 |
Today's Volume 109.377 K | 5 Day Avg. Volume 75.838 K |
PEG Ratio 1.15 | Market Cap. ₹ 35,720.00 Cr. |
Returns Comparison
| Time | AJANTPHARM | VS | Industry |
|---|---|---|---|
| 1 Day | 0.02% | -0.25% | |
| 1 Week | 4.02% | -1.97% | |
| 1 Month | -5.81% | -5.24% | |
| 6 Months | 11.37% | 13.56% | |
| 1 Year | 44.69% | 45.64% |
Technical Trend
Neutral
Bearish
Neutral
Bullish
Pivot Levels
R3 ₹ 2,990.74
R2 ₹ 2,954.46
R1 ₹ 2,926.04
RESISTANCE
₹ 2,889.76
SUPPORT
S1 ₹ 2,861.34
S2 ₹ 2,825.06
S3 ₹ 2,796.64
Moving Averages
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
4
Buy
2
| Period (Days) | SMA | Indication |
|---|---|---|
| 10 | 2857.84 | Bullish |
| 20 | 2903.85 | Bearish |
| 30 | 2998.07 | Bearish |
| 50 | 3084.15 | Bearish |
| 100 | 2927.31 | Bearish |
| 200 | 2659.02 | Bullish |
Shareholding Updates
66.26%
Promoters
Sep 2024
Promoters 66.26%
FII 9.11%
DII 17.11%
Public 7.52%
Others 0%
Cash Flow
| Annual | FY 2024 | FY 2023 | FY 2022 | ||||
|---|---|---|---|---|---|---|---|
| Operating Activities | 785.07 | 792.11 | 561.71 | ||||
| Investing Activities | 65.39 | -559.60 | -74.10 | ||||
| Financing Activities | -1051.06 | -108.20 | -459.71 | ||||
| Net Cash Flow | -200.60 | 124.31 | 27.90 |
All Figures in ₹ Cr., unless mentioned otherwise
Ratios
Return on Equity (%)
Income Statement
All Figures in ₹ Cr., unless mentioned otherwise
Balance Sheet
All Figures in ₹ Cr., unless mentioned otherwise
Peer Comparison
| Name | 1D (%) | 1W (%) | 1M (%) | 6M (%) | 1Y (%) |
|---|---|---|---|---|---|
| Ajanta Pharmaceuticals | 0.02 | 4.02 | -5.81 | 11.37 | 44.69 |
| Aarti Drugs | -1.19 | -4.25 | -7.3 | -1.12 | 3.37 |
| Abbott India | 0.2 | -5.22 | -6.46 | -0.3 | 20.29 |
| Advanced Enzyme Tech | -1.49 | -5.52 | -17.71 | -4.78 | 13.63 |
| Alembic | -2.18 | -8.46 | -1.4 | -8.46 | -8.46 |
Returns as on 21 Nov, 2024
About Ajanta Pharmaceuticals
Ajanta Pharma Limited is an India-based specialty pharmaceutical company. It provides a comprehensive range of specialty branded generic products targeting a broad range of chronic and acute therapies. It is focused on branded generic businesses across India, Asia and Africa. It has a wide range of therapeutic segments, such as cardiology, anti-diabetes, ophthalmology, dermatology, antibiotic, anti-malarial, pain, respiratory, gynecology, pediatric and general health products. Its business also consists of two verticals: the United States generics and the institutional business in Africa. Its ophthalmology products include Bimat (anti glaucoma), Nepaflam (anti-inflammatory), Softdrops (lubricant), and Olopat (anti-allergic). Its cardiology products include MET XL, Atorfit CV, Antihypertensive Cinod, Rosutor Gold, Dapalex and Vilatin. Its subsidiaries include Ajanta Pharma (Mauritius) Limited, Ajanta Pharma USA Inc., Ajanta Pharma Philippines Inc., and Ajanta Pharma Nigeria Limited.
Ajanta Pharmaceuticals Share Price
Ajanta Pharma Limited is an Indian company primarily engaged in the development, manufacture and distribution of ready-made specialty medicines. The company's marketing network operates in domestic and international markets. The company produces a wide range of specialty products targeting different therapeutic segments for patient care and tailored to each market area in which it operates. The generic sea trade is spread across India and about 30 developing countries in Africa, Southeast Asia and West Asia and the Commonwealth of Independent States (CIS). Its product range includes advanced technology products. The company has also made significant investments in its research and development (R&D) facilities.
Ajanta Pharmaceuticals FAQs
How to Buy Ajanta Pharmaceuticals Share?
To purchase Ajanta Pharmaceuticals shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Ajanta Pharmaceuticals (ticker symbol: AJANTPHARM) on the trading platform provided by your broker and purchase the shares.
What's Ajanta Pharmaceuticals share price today?
The stock price of Ajanta Pharmaceuticals as of 21 Nov 2024 is ₹2,897.61
What is the Market Cap of Ajanta Pharmaceuticals?
Market capitalisation represents the total market value of a company's outstanding shares. As of 21 Nov 2024, Ajanta Pharmaceuticals (ticker symbol: AJANTPHARM) has a market capitalisation of approximately ₹3,57,20,00,00,000.00
What is the PE and PB ratio of Ajanta Pharmaceuticals?
Ajanta Pharmaceuticals Ltd's price-to-book ratio as of 21 Nov 2024 is 10.24, reflecting the market's valuation compared to its asset value. As of 21 Nov 2024, the trailing twelve months P/E (price-to-earnings) ratio is 44.7, indicating the market values the company at around ₹44.70 for every ₹1 of earnings
What is the 52 Week High and Low of Ajanta Pharmaceuticals Share?
Ajanta Pharmaceuticals Ltd (AJANTPHARM) hit its 52-week high at ₹3,459.84, and its 52-week low at ₹1,896.16.
Want to learn and earn in Stocks?